Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2017 | Aug. 10, 2017 | |
Document And Entity Information | ||
Entity Registrant Name | Youngevity International, Inc. | |
Entity Central Index Key | 1,569,329 | |
Document Type | 10-Q | |
Document Period End Date | Jun. 30, 2017 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Is Entity a Well-known Seasoned Issuer | No | |
Is Entity a Voluntary Filer | No | |
Is Entity's Reporting Status Current | Yes | |
Entity Filer Category | Smaller Reporting Company | |
Trading Symbol | YGYI | |
Entity Common Stock, Shares Outstanding | 19,678,166 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2,017 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 | |
Current Assets | |||
Cash and cash equivalents | $ 903 | $ 869 | |
Accounts receivable, due from factoring company | 2,743 | 1,078 | |
Trade accounts receivable, net | 843 | 1,071 | |
Income tax receivable | 1,784 | 311 | |
Inventory, net | 20,674 | 21,492 | |
Prepaid expenses and other current assets | 2,910 | 3,087 | |
Total current assets | 29,857 | 27,908 | |
Property and equipment, net | 13,997 | 14,006 | |
Deferred tax assets | 2,857 | 2,857 | |
Intangible assets, net | 16,249 | 14,914 | |
Goodwill | 6,323 | 6,323 | |
Total assets | 69,283 | 66,008 | |
Current Liabilities | |||
Accounts payable | 9,493 | 8,174 | |
Accrued distributor compensation | 4,832 | 4,163 | |
Accrued expenses | 5,210 | 3,701 | |
Deferred revenues | 1,848 | 1,870 | |
Other current liabilities, net | 3,739 | 2,389 | |
Capital lease payable | 891 | 821 | |
Notes payable | 203 | 219 | |
Warrant derivative liability | 4,076 | 3,345 | |
Contingent acquisition debt | 359 | 628 | |
Total current liabilities | 30,651 | 25,310 | |
Capital lease payable, net of current portion | 1,210 | 1,569 | |
Notes payable, net of current portion | 4,393 | 4,431 | |
Convertible notes payable, net of debt discount | [1] | 9,098 | 8,327 |
Contingent acquisition debt, net of current portion | 9,058 | 7,373 | |
Total liabilities | 54,410 | 47,010 | |
Commitments and contingencies, Note 1 | |||
Stockholders' Equity | |||
Convertible Preferred Stock, $0.001 par value: 5,000,000 shares authorized; 161,135 shares issued and outstanding at June 30, 2017 and December 31, 2016 | 0 | 0 | |
Common Stock, $0.001 par value: 50,000,000 shares authorized; 19,668,166 and 19,634,345 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively (1) | 20 | 20 | |
Additional paid-in capital | 170,862 | 170,212 | |
Accumulated deficit | (155,805) | (151,016) | |
Accumulated other comprehensive loss | (204) | (218) | |
Total stockholders' equity | 14,873 | 18,998 | |
Total Liabilities and Stockholders' Equity | $ 69,283 | $ 66,008 | |
[1] | Principal amounts are net of unamortized debt discounts and issuance costs of $3,226,000 as of March 31, 2017 and $3,611,000 as of December 31, 2016. |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Jun. 30, 2017 | Dec. 31, 2016 |
Equity: | ||
Convertible Preferred Stock, par value | $ 0.001 | $ 0.001 |
Convertible Preferred Stock, shares authorized | 100,000,000 | 100,000,000 |
Convertible Preferred Stock, shares issued | 161,135 | 161,135 |
Convertible Preferred Stock, shares outstanding | 161,135 | 161,135 |
Common Stock, par value | $ 0.001 | $ 0.001 |
Common Stock, shares authorized | 600,000,000 | 600,000,000 |
Common Stock, shares issued | 19,668,166 | 19,634,345 |
Common Stock, shares outstanding | 19,668,166 | 19,634,345 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2017 | Jun. 30, 2016 | |
Condensed Consolidated Statements Of Operations | ||||
Revenues | $ 41,527 | $ 42,500 | $ 80,260 | $ 80,702 |
Cost of revenues | 17,425 | 17,069 | 34,292 | 31,908 |
Gross profit | 24,102 | 25,431 | 45,968 | 48,794 |
Operating expenses | ||||
Distributor compensation | 16,686 | 16,796 | 32,105 | 32,770 |
Sales and marketing | 2,901 | 2,637 | 6,576 | 4,438 |
General and administrative | 5,191 | 4,474 | 10,363 | 8,899 |
Total operating expenses | 24,778 | 23,907 | 49,044 | 46,107 |
Operating (loss) income | (676) | 1,524 | (3,076) | 2,687 |
Interest expense, net | (1,258) | (1,089) | (2,455) | (2,193) |
Change in fair value of warrant derivative liability | (1,341) | (484) | (731) | 166 |
Total other expense | (2,599) | (1,573) | (3,186) | (2,027) |
(Loss) income before income taxes | (3,275) | (49) | (6,262) | 660 |
Income tax (benefit) provision | (545) | 60 | (1,473) | 618 |
Net (loss) income | (2,730) | (109) | (4,789) | 42 |
Preferred stock dividends | (3) | (3) | (6) | (6) |
Net (loss) income attributable to common stockholders | $ (2,733) | $ (112) | $ (4,795) | $ 36 |
Net (loss) income per share, basic | $ (0.14) | $ (0.01) | $ (0.24) | $ 0 |
Net (loss) income per share, diluted | $ (0.14) | $ (0.01) | $ (0.24) | $ 0 |
Weighted average shares outstanding, basic | 19,651,705 | 19,630,030 | 19,643,486 | 19,629,913 |
Weighted average shares outstanding, diluted | 19,651,705 | 19,630,030 | 19,643,486 | 19,984,044 |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2017 | Jun. 30, 2016 | |
Condensed Consolidated Statements Of Comprehensive Income Loss | ||||
Net (loss) income | $ (2,730) | $ (109) | $ (4,789) | $ 42 |
Foreign currency translation | (67) | (37) | (14) | (146) |
Total other comprehensive loss | (67) | (37) | (14) | (146) |
Comprehensive loss | $ (2,797) | $ (146) | $ (4,803) | $ (104) |
Condensed Consolidated Stateme6
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2017 | Jun. 30, 2016 | |
Cash Flows from Operating Activities: | ||
Net (loss) income | $ (4,789) | $ 42 |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||
Depreciation and amortization | 2,099 | 1,987 |
Stock based compensation expense | 485 | 126 |
Amortization of deferred financing costs | 180 | 180 |
Amortization of prepaid advisory fees | 28 | 31 |
Stock issuance for services | 150 | 30 |
Change in fair value of warrant derivative liability | 731 | (166) |
Amortization of debt discount | 527 | 527 |
Amortization of warrant issuance costs | 64 | 64 |
Expenses allocated in profit sharing agreement | (420) | (382) |
Change in fair value of contingent acquisition debt | (680) | (871) |
Changes in operating assets and liabilities, net of effect from business combinations: | ||
Accounts receivable | (1,437) | (391) |
Inventory | 818 | (2,301) |
Income taxes receivable | (1,473) | 173 |
Prepaid expenses and other current assets | 149 | (67) |
Accounts payable | 1,319 | 458 |
Accrued distributor compensation | 669 | 738 |
Deferred revenues | (22) | (465) |
Accrued expenses and other liabilities | 1,426 | (1,027) |
Net Cash Used In Operating Activities | (176) | (1,314) |
Cash Flows from Investing Activities: | ||
Acquisitions, net | (175) | 0 |
Purchases of property and equipment | (499) | (461) |
Net Cash Used in Investing Activities | (674) | (461) |
Cash Flows from Financing Activities: | ||
Proceeds from the exercise of stock options | 21 | 12 |
Proceeds from factoring company | 1,652 | 831 |
Payments of notes payable, net | (104) | (358) |
Payments of contingent acquisition debt | (204) | (462) |
Payments of capital leases | (495) | (132) |
Repurchase of common stock | 0 | (20) |
Net Cash Provided by (Used in) Financing Activities | 870 | (129) |
Foreign Currency Effect on Cash | 14 | (146) |
Net increase (decrease) in cash and cash equivalents | 34 | (2,050) |
Cash and Cash Equivalents, Beginning of Period | 869 | 3,875 |
Cash and Cash Equivalents, End of Period | 903 | 1,825 |
Supplemental Disclosures of Cash Flow Information Cash paid during the period for: | ||
Interest | 1,730 | 1,425 |
Income taxes | 31 | 145 |
Supplemental Disclosures of Noncash Investing and Financing Activities | ||
Purchases of property and equipment funded by capital leases | 256 | 1,046 |
Acquisitions of net assets in exchange for contingent acquisition debt (see Note 4) | $ 2,670 | $ 2,650 |
Basis of Presentation and Descr
Basis of Presentation and Description of Business | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Basis of Presentation and Description of Business | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted pursuant to such rules and regulations. The statements presented as of June 30, 2017 and for the three and six months ended June 30, 2017 and 2016 are unaudited. In the opinion of management, these financial statements reflect all normal recurring and other adjustments necessary for a fair presentation, and to make the financial statements not misleading. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Form 10-K for the year ended December 31, 2016. The results for interim periods are not necessarily indicative of the results for the entire year. Youngevity International, Inc. (the “Company”) consolidates all wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications have been made to conform to the current year presentations including the Company’s adoption of Accounting Standards Update (“ASU”) 2015-17 pertaining to the presentation of deferred tax assets and liabilities as noncurrent with retrospective application effective January 1, 2017. This resulted in a reclassification from deferred tax assets, net current to deferred tax assets, net long-term deferred tax assets, net long-term As previously reported on the Annual Report on Form 10-K/A for the year ended December 31, 2016 filed with the Securities and Exchange Commission on August 14, 2017, the Company restated the interim Consolidated Statement of Cash Flows for the quarter ended June 30, 2016 previously filed by the Company in its quarterly report on Form 10-Q for the same period. This was due to an error in the presentation of cash flow activity under the Company’s factoring facility. The current report for the quarter ended June 30, 2017 reflects the restated numbers for the six months ended June 30, 2016. Nature of Business The Company, founded in 1996, develops and distributes health and nutrition related products through its global independent direct selling network, also known as multi-level marketing, and sells coffee products to commercial customers. The Company operates in two business segments, its direct selling segment where products are offered through a global distribution network of preferred customers and distributors and its commercial coffee segment where products are sold directly to businesses. In the following text, the terms “we,” “our,” and “us” may refer, as the context requires, to the Company or collectively to the Company and its subsidiaries. The Company operates through the following domestic wholly-owned subsidiaries: AL Global Corporation, which operates our direct selling networks, CLR Roasters, LLC (“CLR”), our commercial coffee business, 2400 Boswell LLC, MK Collaborative LLC, Youngevity Global LLC and the wholly-owned foreign subsidiaries Youngevity Australia Pty. Ltd., Youngevity NZ, Ltd., Siles Plantation Family Group S.A. (“Siles”), located in Nicaragua, Youngevity Mexico S.A. de CV, Youngevity Israel, Ltd., Youngevity Russia, LLC, Youngevity Colombia S.A.S, Youngevity International Singapore Pte. Ltd., Mialisia Canada, Inc., Legacy for Life Limited (Hong Kong), BellaVita Group LLC; Taiwan, Hong Kong, Singapore, Indonesia, Malaysia and Japan. The Company also operates subsidiary branches of Youngevity Global LLC in the Philippines and Taiwan. Reverse Stock Split On June 5, 2017, the Company filed a certificate to amend its Articles of Incorporation to effect a reverse split on a one-for-twenty basis (the “Reverse Split”), whereby, every twenty shares of the Company’s common stock, par value $0.001 per share (the “Common Stock or “common stock”), were exchanged for one share of its common stock. The Reverse Split became effective on June 7, 2017. All common stock share and per share amounts have been adjusted to reflect retrospective application of the Reverse Split, unless otherwise indicated. The Common Stock began trading on a reverse split basis at the market opening on June 8, 2017. NASDAQ Listing Effective June 21, 2017, the Common Stock began trading on the NASDAQ Stock Market LLC’s NASDAQ Capital Market, under the symbol “YGYI”. Prior to the Company’s uplisting to NASDAQ the Company’s common stock had been traded on the OTCQX market. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense for each reporting period. Estimates are used in accounting for, among other things, allowances for doubtful accounts, deferred taxes, and related valuation allowances, fair value of derivative liabilities, uncertain tax positions, loss contingencies, fair value of options granted under our stock based compensation plan, fair value of assets and liabilities acquired in business combinations, capital leases, asset impairments, estimates of future cash flows used to evaluate impairments, useful lives of property, equipment and intangible assets, value of contingent acquisition debt, inventory obsolescence, and sales returns. Actual results may differ from previously estimated amounts and such differences may be material to the condensed consolidated financial statements. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected prospectively in the period they occur. Liquidity We believe that current cash balances, future cash provided by operations, and available amounts under our accounts receivable factoring agreement will be sufficient to cover our operating and capital needs in the ordinary course of business for at least the next twelve months as of August 14, 2017. Though our operations are currently meeting our working capital requirements, if we experience an adverse operating environment or unusual capital expenditure requirements, or if we continue our expansion internationally or through acquisitions, additional financing may be required. No assurance can be given, however, that additional financing, if required, would be available on favorable terms. We might also require or seek additional financing for the purpose of expanding into new markets, growing our existing markets, or for other reasons. Such financing may include the use of additional debt or the sale of additional equity securities. Any financing which involves the sale of equity securities or instruments that are convertible into equity securities could result in immediate and possibly significant dilution to our existing shareholders. Cash and Cash Equivalents The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents. Earnings Per Share Basic earnings (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income attributable to common stockholders by the sum of the weighted-average number of common shares outstanding during the period and the weighted-average number of dilutive common share equivalents outstanding during the period, using the treasury stock method. Dilutive common share equivalents are comprised of in-the-money stock options, warrants and convertible preferred stock and Common Stock associated with the Company's convertible notes based on the average stock price for each period using the treasury stock method. Since the Company incurred a loss for the three and six months ended June 30, 2017, 5,282,208 common share equivalents were not included in the weighted-average calculations since their effect would have been anti-dilutive. The Company incurred a loss for the three months ended June 30, 2016, and therefore, 4,866,703 common share equivalents including potential convertible shares of Common Stock associated with the Company's convertible notes were not included in the weighted-average calculation since their effect would have been anti-dilutive. The incremental dilutive common share equivalents were 1,380,915 for the six months ended June 30, 2016. Income and loss per share amounts and weighted average shares outstanding for all periods have been retroactively adjusted to reflect the Company’s 1-for-20 Reverse Split, which was effective June 7, 2017. Stock Based Compensation The Company accounts for stock based compensation in accordance with ASC Topic 718, “ Compensation – Stock Compensation,” The Company accounts for equity instruments issued to non-employees in accordance with authoritative guidance for equity based payments to non-employees. Stock options issued to non-employees are accounted for at their estimated fair value, determined using the Black-Scholes option-pricing model. The fair value of options granted to non-employees is re-measured as they vest, and the resulting increase in value, if any, is recognized as expense during the period the related services are rendered. Factoring Agreement The Company has a factoring agreement (“Factoring Agreement”) with Crestmark Bank (“Crestmark”) related to the Company’s accounts receivable resulting from sales of certain products within its commercial coffee segment. Effective May 1, 2016, the Company entered into a third amendment to the factoring agreement (“Agreement”). Under the terms of the Agreement, all new receivables assigned to Crestmark shall be “Client Risk Receivables” and no further credit approvals will be provided by Crestmark. Additionally, the Agreement expands the factoring facility to include advanced borrowings against eligible inventory up to 50% of landed cost of finished goods inventory that meet certain criteria, not to exceed the lesser of $1,000,000 or 85% of the value of the accounts receivables already advanced with a maximum overall borrowing of $3,000,000. Interest accrues on the outstanding balance and a factoring commission is charged for each invoice factored which is calculated as the greater of $5.00 or 0.75% to 0.875% of the gross invoice amount and is recorded as interest expense. In addition, the Company and the Company’s CEO, Mr. Wallach have entered into a Guaranty and Security Agreement with Crestmark Bank guaranteeing payments in the event that CLR were to default. This Agreement is effective until February 1, 2019. The Company accounts for the sale of receivables under the Factoring Agreement as secured borrowings with a pledge of the subject inventories and receivables as well as all bank deposits as collateral, in accordance with the authoritative guidance for accounting for transfers and servicing of financial assets and extinguishments of liabilities. The caption “Accounts receivable, due from factoring company” on the accompanying condensed consolidated balance sheets in the amount of approximately $2,743,000 and $1,078,000 as of June 30, 2017 and December 31, 2016, respectively, reflects the related collateralized accounts. The Company's outstanding liability related to the Factoring Agreement was approximately $2,942,000 and $1,290,000 as of June 30, 2017 and December 31, 2016, respectively, and is included in other current liabilities on the condensed consolidated balance sheets. Plantation Costs The Company’s commercial coffee segment CLR includes the results of the Siles Plantation Family Group (“Siles”), which is a 500 acre coffee plantation and a dry-processing facility located on 26 acres both located in Matagalpa, Nicaragua. Siles is a wholly-owned subsidiary of CLR, and the results of CLR include the depreciation and amortization of capitalized costs, development and maintenance and harvesting costs of Siles. In accordance with US generally accepted accounting principles (“GAAP”), plantation maintenance and harvesting costs for commercially producing coffee farms are charged against earnings when sold. Deferred harvest costs accumulate throughout the year, and are expensed over the remainder of the year as the coffee is sold. The difference between actual harvest costs incurred and the amount of harvest costs recognized as expense is recorded as either an increase or decrease in deferred harvest costs, which is reported as an asset and included with prepaid expenses and other current assets in the condensed consolidated balance sheets. Once the harvest is complete, the harvest cost is then recognized as the inventory value. As of December 31, 2016, the inventory related to the 2016 harvest was $112,000. As of June 30, 2017, all previously harvested coffee from the 2016 harvest had been sold. In April 2017, the Company completed the 2017 harvest in Nicaragua and approximately $552,000 of deferred harvest costs were reclassified as inventory during the quarter ended June 30, 2017. The remaining inventory as of June 30, 2017 is $391,000. Costs associated with the 2018 harvest as of June 30, 2017 total approximately $100,000 and are included in prepaid expenses and other current assets as deferred harvest costs on the Company’s condensed consolidated balance sheets. Related Party Transactions Richard Renton Richard Renton is a member of the Board of Directors and owns and operates with his wife Roxanna Renton, Northwest Nutraceuticals, Inc., a supplier of certain inventory items sold by the Company. The Company made purchases of approximately $59,000 and $16,000 from Northwest Nutraceuticals Inc., for the three months ended June 30, 2017 and 2016, respectively, and $81,000 and $50,000 for the six months ended June 30, 2017 and 2016, respectively. In addition, Mr. Renton and his wife are distributors of the Company and can earn commissions on product sales. Other Relationships Hernandez, Hernandez, Export Y Company The Company’s coffee segment, CLR, is associated with Hernandez, Hernandez, Export Y Company (“H&H”), a Nicaragua company, through sourcing arrangements to procure Nicaraguan green coffee beans and in March 2014 as part of the Siles acquisition, CLR engaged the owners of H&H as employees to manage Siles. The Company made purchases of approximately $912,000 and $2,900,000 from this supplier for the three months ended June 30, 2017 and 2016, respectively and $1,327,000 and $4,700,000 for the six months ended June 30, 2017 and 2016, respectively. In addition, CLR sold approximately $1,056,000 and $1,500,000 for the three months ended June 30, 2017 and 2016, respectively and $1,547,000 and $2,200,000 for the six months ended June 30, 2017 and 2016, respectively, of green coffee beans to H&H Coffee Group Export, a Florida based company which is affiliated with H&H. In March 2017, the Company entered a settlement agreement and release with H&H Coffee Group Export pursuant to which it was agreed that $150,000 owed to H&H Coffee Group Export for services that had been rendered would be settled by the issuance of Common Stock. During the three months ended June 30, 2017, the Company issued to H&H Coffee Group Export 27,500 shares of Common Stock in accordance with this agreement. In May 2017, the Company entered a settlement agreement with Alain Piedra Hernandez, one of the owners of H&H and the operating manager of Siles, who was issued a non-qualified stock option for the purchase of 75,000 shares of the Company’s Common Stock at a price of $2.00 with an expiration date of three years, in lieu of an obligation due from the Company to H&H as relates to a Sourcing and Supply Agreement with H&H. Revenue Recognition The Company recognizes revenue from product sales when the following four criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. The Company ships the majority of its direct selling segment products directly to the distributors primarily via UPS, USPS or FedEx and receives substantially all payments for these sales in the form of credit card transactions. The Company regularly monitors its use of credit card or merchant services to ensure that its financial risk related to credit quality and credit concentrations is actively managed. Revenue is recognized upon passage of title and risk of loss to customers when product is shipped from the fulfillment facility. The Company ships the majority of its coffee segment products via common carrier and invoices its customer for the products. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. Sales revenue and a reserve for estimated returns are recorded net of sales tax when product is shipped. Deferred Revenues and Costs Deferred revenues relate primarily to the Heritage Makers product line and represent the Company’s obligation for points purchased by customers that have not yet been redeemed for product. Cash received for points sold is recorded as deferred revenue. Revenue is recognized when customers redeem the points and the product is shipped. As of June 30, 2017 and December 31, 2016, the balance in deferred revenues was approximately $1,848,000 and $1,870,000 respectively, of which the portion attributable to Heritage Makers was approximately $1,623,000 and $1,662,000, respectively. The remaining balance of approximately $225,000 and $208,000 as of June 30, 2017 and December 31, 2016, related primarily to the Company’s 2017 conventions, respectively, whereby attendees pre-enroll in the events and the Company does not recognize this revenue until the conventions occur. Deferred costs relate to Heritage Makers prepaid commissions that are recognized in expense at the time the related revenue is recognized. As of June 30, 2017 and December 31, 2016, the balance in deferred costs was approximately $377,000 and $415,000 respectively, and was included in prepaid expenses and current assets. Commitments and Contingencies We are, from time to time, the subject of claims and suits arising out of matters occurring during the operation of our business. We are not presently party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, current legal proceedings are having an adverse impact on us because of litigation costs, diversion of management resources and other factors. Recently Issued Accounting Pronouncements In October 2016, the FASB issued Accounting Standard Update ("ASU") 2016-17, Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control. This standard amends the guidance issued with ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis in order to make it less likely that a single decision maker would individually meet the characteristics to be the primary beneficiary of a Variable Interest Entity ("VIE"). When a decision maker or service provider considers indirect interests held through related parties under common control, they perform two steps. The second step was amended with this ASU to say that the decision maker should consider interests held by these related parties on a proportionate basis when determining the primary beneficiary of the VIE rather than in their entirety as was called for in the previous guidance. This ASU was effective for fiscal years beginning after December 15, 2016, and early adoption was not permitted. The Company adopted ASU 2016-17 effective the quarter ended March 31, 2017. The adoption of ASU 2016-17 did not have a significant impact on its consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. The Company expects to adopt the standard no later than January 1, 2019. The Company is currently assessing the impact that the new standard will have on the Company’s consolidated financial statements, which will consist primarily of a balance sheet gross up of our operating leases. The Company has not evaluated the impact this new standard will have on its consolidated financial statements; however it is expected to gross-up the consolidated balance sheet as a result of recognizing a lease asset along with a similar lease liability. In November 2015, the FASB issued ASU 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. This guidance requires that entities with a classified statement of financial position present all deferred tax assets and liabilities as noncurrent. This update is effective for annual and interim periods for fiscal years beginning after December 15, 2016, which required the Company to adopt the new guidance in the first quarter of fiscal 2017. Early adoption was permitted for financial statements that have not been previously issued and may be applied on either a prospective or retrospective basis. The Company adopted ASU 2015-17 effective the quarter ended March 31, 2017. The adoption of ASU 2015-17 did not have a significant impact on its consolidated financial statements other than the netting of current and long-term deferred tax assets and liabilities in the non-current section of the balance sheet and footnote disclosures. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, requiring an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The updated standard will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either the retrospective or cumulative effect transition method. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. Accordingly, the updated standard is effective for the Company in the first quarter of fiscal 2018 and we do not plan to early adopt. The Company has not yet selected a transition method and the Company is currently evaluating the effect that the updated standard will have on its consolidated financial statements and related disclosures. |
Income Taxes
Income Taxes | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Income Taxes | The Company accounts for income taxes in accordance with ASC Topic 740, “ Income Taxes,” Income taxes for the interim periods are computed using the effective tax rates estimated to be applicable for the full fiscal year, as adjusted for any discrete taxable events that occur during the period. The Company files income tax returns in the United States (“U.S.”) on a federal basis and in many U.S. state and foreign jurisdictions. Certain tax years remain open to examination by the major taxing jurisdictions to which the Company is subject. |
Inventory and Costs of Revenues
Inventory and Costs of Revenues | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Inventory and Costs of Revenues | Inventory is stated at the lower of cost or market value. Cost is determined using the first-in, first-out method. The Company records an inventory reserve for estimated excess and obsolete inventory based upon historical turnover, market conditions and assumptions about future demand for its products. When applicable, expiration dates of certain inventory items with a definite life are taken into consideration. Inventories consist of the following (in thousands): As of June 30, 2017 December 31, 2016 Finished goods $ 10,962 $ 11,550 Raw materials 10,776 11,006 21,738 22,556 Reserve for excess and obsolete (1,064 ) (1,064 ) Inventory, net $ 20,674 $ 21,492 Cost of revenues includes the cost of inventory, shipping and handling costs, royalties associated with certain products, transaction banking costs, warehouse labor costs and depreciation on certain assets. |
Acquisitions and Business Combi
Acquisitions and Business Combinations | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Acquisitions and Business Combinations | The Company accounts for business combinations under the acquisition method and allocates the total purchase price for acquired businesses to the tangible and identified intangible assets acquired and liabilities assumed, based on their estimated fair values. When a business combination includes the exchange of the Company’s Common Stock, the value of the Common Stock is determined using the closing market price as of the date such shares were tendered to the selling parties. The fair values assigned to tangible and identified intangible assets acquired and liabilities assumed are based on management or third-party estimates and assumptions that utilize established valuation techniques appropriate for the Company’s industry and each acquired business. Goodwill is recorded as the excess, if any, of the aggregate fair value of consideration exchanged for an acquired business over the fair value (measured as of the acquisition date) of total net tangible and identified intangible assets acquired. A liability for contingent consideration, if applicable, is recorded at fair value as of the acquisition date. In determining the fair value of such contingent consideration, management estimates the amount to be paid based on probable outcomes and expectations on financial performance of the related acquired business. The fair value of contingent consideration is reassessed quarterly, with any change in the estimated value charged to operations in the period of the change. Increases or decreases in the fair value of the contingent consideration obligations can result from changes in actual or estimated revenue streams, discount periods, discount rates and probabilities that contingencies will be met. During the six months ended June 30, 2017, the Company entered into two acquisitions, which are detailed below. The acquisitions were conducted in an effort to expand the Company’s distributor network, enhance and expand its product portfolio, and diversify its product mix. As such, the major purpose for all of the business combinations was to increase revenue and profitability. The acquisitions were structured as asset purchases which resulted in the recognition of certain intangible assets. BellaVita Group, LLC Effective March 1, 2017, the Company acquired certain assets of BellaVita Group, LLC “BellaVita” a direct sales company and producer of health and beauty products with locations and customers primarily in the Asian market. The contingent consideration’s estimated fair value at the date of acquisition was $1,750,000 as determined by management using a discounted cash flow methodology. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred. In addition, the Company has assumed certain liabilities in accordance with the agreement. The Company is obligated to make monthly payments based on a percentage of the BellaVita distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue derived from sales of BellaVita products until the earlier of the date that is twelve (12) years from the closing date or such time as the Company has paid to BellaVita aggregate cash payments of the BellaVita distributor revenue and royalty revenue equal to a predetermined maximum aggregate purchase price. The assets acquired were recorded at estimated fair values as of the date of the acquisition. The fair values of the acquired assets have not been finalized pending further information that may impact the valuation of certain assets or liabilities. The preliminary purchase price allocation is as follows (in thousands): Distributor organization $ 825 Customer-related intangible 525 Trademarks and trade name 400 Total purchase price $ 1,750 The preliminary fair value of intangible assets acquired was determined through the use of a discounted cash flow methodology. The trademarks and trade name, customer-related intangible and distributor organization intangible are being amortized over their estimated useful life of ten (10) years using the straight-line method which is believed to approximate the time-line within which the economic benefit of the underlying intangible asset will be realized. The Company expects to finalize the valuations within one (1) year from the acquisition date. The revenue impact from the BellaVita acquisition, included in the condensed consolidated statements of operations for the three and six months ended June 30, 2017 was approximately $620,000 and $872,000, respectively. The pro-forma effect assuming the business combination with BellaVita discussed above had occurred at the beginning of the year is not presented as the information was not available. Ricolife, LLC Effective March 1, 2017, the Company acquired certain assets of Ricolife, LLC “Ricolife” a direct sales company and producer of teas with health benefits contained within its tea formulas. The contingent consideration’s estimated fair value at the date of acquisition was $920,000 as determined by management using a discounted cash flow methodology. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred. In addition, the Company has assumed certain liabilities in accordance with the agreement. The Company is obligated to make monthly payments based on a percentage of the Ricolife distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue derived from sales of Ricolife products until the earlier of the date that is twelve (12) years from the closing date or such time as the Company has paid to Ricolife aggregate cash payments of the Ricolife distributor revenue and royalty revenue equal to a predetermined maximum aggregate purchase price. The assets acquired were recorded at estimated fair values as of the date of the acquisition. The fair values of the acquired assets have not been finalized pending further information that may impact the valuation of certain assets or liabilities. The preliminary purchase price allocation is as follows (in thousands): Distributor organization $ 440 Customer-related intangible 280 Trademarks and trade name 200 Total purchase price $ 920 The preliminary fair value of intangible assets acquired was determined through the use of a discounted cash flow methodology. The trademarks and trade name, customer-related intangible and distributor organization intangible are being amortized over their estimated useful life of ten (10) years using the straight-line method which is believed to approximate the time-line within which the economic benefit of the underlying intangible asset will be realized. The Company expects to finalize the valuations within one (1) year from the acquisition date. The revenue impact from the Ricolife acquisition, included in the condensed consolidated statements of operations for the three and six months ended June 30, 2017 was approximately $351,000 and $415,000, respectively. The pro-forma effect assuming the business combination with Ricolife discussed above had occurred at the beginning of the year is not presented as the information was not available. |
Intangible Assets and Goodwill
Intangible Assets and Goodwill | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Intangible Assets and Goodwill | Intangible Assets Intangible assets are comprised of distributor organizations, trademarks and tradenames, customer relationships and internally developed software. The Company's acquired intangible assets, which are subject to amortization over their estimated useful lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an intangible asset may not be recoverable. An impairment loss is recognized when the carrying amount of an intangible asset exceeds its fair value. Intangible assets consist of the following (in thousands): June 30, 2017 December 31, 2016 Cost Accumulated Amortization Net Cost Accumulated Amortization Net Distributor organizations $ 14,195 $ 7,779 $ 6,416 $ 12,930 $ 7,162 $ 5,768 Trademarks and trade names 5,994 988 5,006 5,394 815 4,579 Customer relationships 8,651 4,136 4,515 7,846 3,642 4,204 Internally developed software 720 408 312 720 357 363 Intangible assets $ 29,560 $ 13,311 $ 16,249 $ 26,890 $ 11,976 $ 14,914 Amortization expense related to intangible assets was approximately $690,000 and $605,000 for the three months ended June 30, 2017 and 2016, respectively. Amortization expense related to intangible assets was approximately $1,335,000 and $1,209,000 for the six months ended June 30, 2017 and 2016, respectively. Trade names, which do not have legal, regulatory, contractual, competitive, economic, or other factors that limit the useful lives are considered indefinite lived assets and are not amortized but are tested for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Approximately $2,267,000 in trademarks from business combinations have been identified as having indefinite lives. Goodwill Goodwill is recorded as the excess, if any, of the aggregate fair value of consideration exchanged for an acquired business over the fair value (measured as of the acquisition date) of total net tangible and identified intangible assets acquired. In accordance with Financial Accounting Standards Board (“FASB”) ASC Topic 350, “Intangibles — Goodwill and Other”, The Company first assesses qualitative factors to determine whether it is more likely than not (a likelihood of more than 50%) that goodwill is impaired. After considering the totality of events and circumstances, the Company determines whether it is more likely than not that goodwill is not impaired. If impairment is indicated, then the Company conducts the two-step impairment testing process. The first step compares the Company’s fair value to its net book value. If the fair value is less than the net book value, the second step of the test compares the implied fair value of the Company’s goodwill to its carrying amount. If the carrying amount of goodwill exceeds its implied fair value, the Company would recognize an impairment loss equal to that excess amount. The testing is generally performed at the “reporting unit” level. A reporting unit is the operating segment, or a business one level below that operating segment (referred to as a component) if discrete financial information is prepared and regularly reviewed by management at the component level. The Company has determined that its reporting units for goodwill impairment testing are the Company’s reportable segments. As such, the Company analyzed its goodwill balances separately for the commercial coffee reporting unit and the direct selling reporting unit. The goodwill balance as of June 30, 2017 and December 31, 2016 was $6,323,000. There were no triggering events indicating impairment of goodwill or intangible assets during the three and six months ended June 30, 2017 and 2016. Goodwill intangible assets consist of the following (in thousands): June 30, 2017 December 31, 2016 Goodwill, commercial coffee $ 3,314 $ 3,314 Goodwill, direct selling 3,009 3,009 Total goodwill $ 6,323 $ 6,323 |
Debt
Debt | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Debt | Convertible Notes Payable Our total convertible notes payable as of June 30, 2017, net of debt discount outstanding consisted of the amount set forth in the following table (in thousands): June 30, 2017 December 31, 2016 8% Convertible Notes due July and August 2019 (July 2014 Private Placement) (1) $ 2,771 $ 2,296 8% Convertible Notes due October and November 2018 (November 2015 Private Placement) (2) 7,051 6,999 Net debt issuance costs (724 ) (968 ) Total convertible notes payable, net of debt discount (3) $ 9,098 $ 8,327 (1) Principal amount of $4,750,000 is net of unamortized debt discounts of $1,979,000 as of June 30, 2017 and $2,454,000 as of December 31, 2016. (2) Principal amount of approximately $7,188,000 is net of unamortized debt discounts of $137,000 as of June 30, 2017 and $189,000 as of December 31, 2016. (3) Principal amounts are net of unamortized debt discounts and issuance costs of $2,840,000 as of June 30, 2017 and $3,611,000 as of December 31, 2016. (See Note 11 Subsequent Events, “July 2017 Private Placement” below.) July 2014 Private Placement Between July 31, 2014 and September 10, 2014 the Company entered into Note Purchase Agreements (the “Note” or “Notes”) related to its private placement offering (“2014 Private Placement”) with seven accredited investors pursuant to which the Company raised aggregate gross proceeds of $4,750,000 and sold units consisting of five (5) year senior secured convertible Notes in the aggregate principal amount of $4,750,000 that are convertible into 678,568 shares of our Common Stock, at a conversion price of $7.00 per share, and warrants to purchase 929,346 shares of Common Stock at an exercise price of $4.60 per share. The Notes bear interest at a rate of eight percent (8%) per annum and interest is paid quarterly in arrears with all principal and unpaid interest due between July and September 2019. As of June 30, 2017 and December 31, 2016 the principal amount of $4,750,000 remains outstanding. The Company recorded debt discounts of $4,750,000 related to the beneficial conversion feature of $1,053,000 and a debt discount of $3,697,000 related to the detachable warrants discount. The beneficial conversion feature discount and the detachable warrants discount are amortized to interest expense over the life of the Notes. As of June 30, 2017 and December 31, 2016 the remaining balances of the debt discounts is approximately $1,979,000 and $2,454,000, respectively. The quarterly amortization of the issuance costs is approximately $238,000 and is recorded as interest expense. With respect to the aggregate offering, the Company paid $490,000 in expenses including placement agent fees. The issuance costs are amortized to interest expense over the term of the Notes. As of June 30, 2017 and December 31, 2016 the remaining balances of the issuance cost is approximately $204,000 and $253,000, respectively. The quarterly amortization of the issuance costs is approximately $25,000 and is recorded as interest expense. Unamortized debt discounts and issuance costs are included with convertible notes payable, net of debt discount on the condensed consolidated balance sheets. November 2015 Private Placement Between October 13, 2015 and November 25, 2015 the Company entered into Note Purchase Agreements (the “Note” or “Notes”) related to its private placement offering (“November 2015 Private Placement”) with three (3) accredited investors pursuant to which the Company raised cash proceeds of $3,187,500 in the offering and converted $4,000,000 of debt from the January 2015 Private Placement to this offering in consideration of the sale of aggregate units consisting of three-year senior secured convertible Notes in the aggregate principal amount of $7,187,500, convertible into 1,026,784 shares of Common Stock, at a conversion price of $7.00 per share, subject to adjustment as provided therein; and five-year Warrants exercisable to purchase 479,166 shares of the Company’s common stock at a price per share of $9.00. The Notes bear interest at a rate of eight percent (8%) per annum and interest is paid quarterly in arrears with all principal and unpaid interest due at maturity on October 12, 2018. As of June 30, 2017 and December 31, 2016 the principal amount of $7,187,500 remains outstanding. (See Note 11 Subsequent Events, “July 2017 Private Placement” below.) The Company recorded debt discounts of $309,000 related to the beneficial conversion feature of $15,000 and a debt discount of $294,000 related to the detachable warrants discount. The beneficial conversion feature discount and the detachable warrants discount are amortized to interest expense over the life of the Notes. As of June 30, 2017 and December 31, 2016 the remaining balances of the debt discounts is approximately $137,000 and $189,000 respectively. The quarterly amortization of the issuance costs is approximately $26,000 and is recorded as interest expense. With respect to the aggregate offering, the Company paid $786,000 in expenses including placement agent fees. The issuance costs are amortized to interest expense over the term of the Notes. As of June 30, 2017 and December 31, 2016 the remaining balances of the issuance cost is approximately $349,000 and $480,000, respectively. The quarterly amortization of the issuance costs is approximately $65,000 and is recorded as interest expense. In addition the Company issued warrants to the placement agent in connection with the Notes which were valued at approximately $384,000. These warrants were not protected against down-round financing and accordingly, were classified as equity instruments and corresponding deferred issuance costs are amortized over the term of the Notes. As of June 30, 2017 and December 31, 2016, the remaining balance of the warrant issuance costs is approximately $171,000 and $235,000, respectively. The quarterly amortization of the warrant issuance costs is approximately $32,000 and is recorded as interest expense. Unamortized debt discounts and issuance costs are included with convertible notes payable, net of debt discount on the condensed consolidated balance sheets. |
Derivative Liability
Derivative Liability | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Derivative Liability | The Company accounted for the warrants issued in conjunction with our November 2015 and July 2014 Private Placements in accordance with the accounting guidance for derivatives ASC Topic 815. The accounting guidance sets forth a two-step model to be applied in determining whether a financial instrument is indexed to an entity’s own stock, which would qualify such financial instruments for a scope exception. This scope exception specifies that a contract that would otherwise meet the definition of a derivative financial instrument would not be considered as such if the contract is both (i) indexed to the entity’s own stock and (ii) classified in the stockholders’ equity section of the entity’s balance sheet. The Company determined the warrants issued to the investors that relate to Notes are ineligible for equity classification due to anti-dilution provisions set forth therein. Warrants classified as derivative liabilities are recorded at their estimated fair value (see Note 8, below) at the issuance date and are revalued at each subsequent reporting date. The Company will continue to revalue the derivative liability on each subsequent balance sheet date until the securities to which the derivative liabilities relate are exercised or expire. The estimated fair value of the outstanding warrant liabilities was $4,076,000 and $3,345,000 as of June 30, 2017 and December 31, 2016, respectively. Increases or decreases in fair value of the derivative liability are included as a component of total other expense in the accompanying condensed consolidated statements of operations for the respective period. The changes to the derivative liability for warrants resulted in an increase to the liability of approximately $1,341,000 for the three months ended June 30, 2017 compared to an increase to the liability of approximately $484,000 for the three months ended June 30, 2016. For the six months ended June 30, 2017 the liability increased by approximately $731,000 compared to a decrease of approximately $166,000 for the six months ended June 30, 2016. Various factors are considered in the pricing models the Company uses to value the warrants, including its current stock price, the remaining life of the warrants, the volatility of its stock price, and the risk free interest rate. Future changes in these factors may have a significant impact on the computed fair value of the warrant liability. As such, the Company expects future changes in the fair value of the warrants to continue and may vary significantly from period to period. The warrant liability and revaluations have not had a cash impact on our working capital, liquidity or business operations. The estimated fair value of the warrants were computed as of June 30, 2017 and as of December 31, 2016 using Black-Scholes and Monte Carlo option pricing models, using the following assumptions: June 30, 2017 December 31, 2016 Stock price volatility 60% - 65 % 60% - 65 % Risk-free interest rates 1.38%-1.55 % 1.34%-1.70 % Annual dividend yield 0 0 Expected life 2.0-3.3 years 2.6-3.9 years In addition, management assessed the probabilities of future financing assumptions in the valuation models. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Fair Value of Financial Instruments | Fair value measurements are performed in accordance with the guidance provided by ASC Topic 820, “Fair Value Measurements and Disclosures.” ASC Topic 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities recorded at fair value in the financial statements are categorized based upon the hierarchy of levels of judgment associated with the inputs used to measure their fair value. Hierarchical levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: Level 1 – Quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. Level 2 – Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3 – Unobservable inputs that are supportable by little or no market activity and that are significant to the fair value of the asset or liability. The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, capital lease obligations and deferred revenue approximate their fair values based on their short-term nature. The carrying amount of the Company’s long term notes payable approximates its fair value based on interest rates available to the Company for similar debt instruments and similar remaining maturities. The estimated fair value of the contingent consideration related to the Company's business combinations is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. In connection with the 2015 and 2014 Private Placements, the Company issued warrants to purchase shares of its common stock which are accounted for as derivative liabilities (see Note 7 above.) The estimated fair value of the warrants is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The following table details the fair value measurement within the three levels of the value hierarchy of the Company’s financial instruments, which includes the Level 3 liabilities (in thousands): Fair Value at June 30, 2017 Total Level 1 Level 2 Level 3 Liabilities: Contingent acquisition debt, current portion $ 359 $ - $ - $ 359 Contingent acquisition debt, less current portion 9,058 - - 9,058 Warrant derivative liability 4,076 - - 4,076 Total liabilities $ 13,493 $ - $ - $ 13,493 Fair Value at December 31, 2016 Total Level 1 Level 2 Level 3 Liabilities: Contingent acquisition debt, current portion $ 628 $ - $ - $ 628 Contingent acquisition debt, less current portion 7,373 - - 7,373 Warrant derivative liability 3,345 - - 3,345 Total liabilities $ 11,346 $ - $ - $ 11,346 The fair value of the contingent acquisition liabilities are evaluated each reporting period using projected revenues, discount rates, and projected timing of revenues. Projected contingent payment amounts are discounted back to the current period using a discount rate. Projected revenues are based on the Company’s most recent internal operational budgets and long-range strategic plans. Increases in projected revenues will result in higher fair value measurements. Increases in discount rates and the time to payment will result in lower fair value measurements. Increases (decreases) in any of those inputs in isolation may result in a significantly lower (higher) fair value measurement. During the three and six months ended June 30, 2017 the net adjustment to the fair value of the contingent acquisition debt was a decrease of $680,000. During the three and six months ended June 30, 2016 the net adjustment to the fair value of the contingent acquisition debt was a decrease of $480,000 and a decrease of $871,000, respectively. |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Stockholders' Equity | The Company’s Articles of Incorporation, as amended, authorize the issuance of two classes of stock to be designated “Common Stock” and “Preferred Stock”. Common Stock On May 31, 2017, the Board of Directors of the Company authorized a reverse stock split in order to meet certain criteria in preparation for the Company’s uplisting on the NASDAQ Capital Market. On June 5, 2017, the Company filed a certificate of amendment to the Company’s Articles of Incorporation with the Secretary of State of the State of Delaware to effect a one-for-twenty reverse stock split of the Company’s issued and outstanding common stock. As a result of the Reverse Split, every twenty shares of the Company issued and outstanding common stock were automatically combined and reclassified into one share of the Company’s common stock. The Reverse Split affected all issued and outstanding shares of common stock, as well as common stock underlying stock options, warrants outstanding, including common stock equivalents issuable under convertible notes and preferred shares. No fractional shares were issued in connection with the Reverse Split. Stockholders who would otherwise hold a fractional share of common stock will receive cash payment for the fractional share. The Reverse Split became effective on June 7, 2017. All disclosures of shares and per share data in these condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the Reverse Split for all periods presented. The total number of authorized shares of common stock was reduced from 600,000,000 to 50,000,000. The total number of shares of stock which the Corporation shall have authority to issue is 50,000,000 shares of common stock, par value $.001 per share and 5,000,000 shares of preferred stock, par value $.001 per share, of which 161,135 shares have been designated as Series A convertible preferred stock, par value $.001 per share (“Series A Convertible Preferred”). As of June 30, 2017, the total number of authorized shares of common stock was is 50,000,000. As of June 30, 2017, and December 31, 2016 there were 19,668,166 and 19,634,345 shares of common stock outstanding, respectively. The holders of the Common Stock are entitled to one vote for each share held at all meetings of stockholders (and written actions in lieu of meetings). Convertible Preferred Stock The Company had 161,135 shares of Series A Convertible Preferred Stock outstanding as of June 30, 2017 and December 31, 2016, and accrued dividends of approximately $118,000 and $112,000, respectively. The holders of the Series A Convertible Preferred Stock are entitled to receive a cumulative dividend at a rate of 8.0% per year, payable annually either in cash or shares of the Company's Common Stock at the Company's election. Shares of Common Stock paid as accrued dividends are valued at $10.00 per share. Each share of Series A Convertible Preferred is convertible into two shares of the Company's Common Stock. The holders of Series A Convertible Preferred are entitled to receive payments upon liquidation, dissolution or winding up of the Company before any amount is paid to the holders of Common Stock. The holders of Series A Convertible Preferred have no voting rights, except as required by law. Repurchase of Common Stock On December 11, 2012, the Company authorized a share repurchase program to repurchase up to 750,000 of the Company's issued and outstanding shares of Common Stock from time to time on the open market or via private transactions through block trades. A total of 196,594 shares have been repurchased to-date as of June 30, 2017 at a weighted-average cost of $5.30. There were no repurchases during the six months ended June 30, 2017. The remaining number of shares authorized for repurchase under the plan as of June 30, 2017 is 553,406. Advisory Agreements PCG Advisory Group. As of June 30, 2017, the Company has issued 5,000 shares of restricted common stock in connection with this agreement and accrued for the estimated per share value on each subsequent six (6) month periods based on the price of Company’s common stock at each respective date. As of June 30, 2017, the Company has accrued for 10,000 shares of restricted stock that have been earned. The fair value of the shares to be issued are recorded as prepaid advisory fees and are included in prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets and is amortized on a pro-rata basis over the term of the respective periods. During the three months ended June 30, 2017 and 2016, the Company recorded expense of approximately $14,000 and $15,000, respectively and $28,000 and $31,000, during the six months ended June 30, 2017 and 2016, respectively, in connection with amortization of the stock issuance. Warrants to Purchase Preferred Stock and Common Stock As of June 30, 2017, warrants to purchase 1,883,885 shares of the Company's common stock at prices ranging from $4.60 to $10.00 were outstanding. All warrants are exercisable as of June 30, 2017 and expire at various dates through November 2020 and have a weighted average remaining term of approximately 2.27 years and are included in the table below as of June 30, 2017. A summary of the warrant activity for the six months ended June 30, 2017 is presented in the following table: Balance at December 31, 2016 1,899,385 Issued - Expired / cancelled (15,500 ) Exercised - Balance at June 30, 2017 1,883,885 Stock Options On May 16, 2012, the Company established the 2012 Stock Option Plan (“Plan”) authorizing the granting of options for up to 2,000,000 shares of Common Stock. On February 23, 2017, the Company’s board of directors received the approval of our stockholders, to amend the 2012 Stock Option Plan (“Plan”) to increase the number of shares of common stock available for grant and to expand the types of awards available for grant under the Plan. The amendment of the Plan increased the number of authorized shares of the Company’s common stock that may be delivered pursuant to awards granted during the life of the plan from 2,000,000 to 4,000,000 shares. The purpose of the Plan is to promote the long-term growth and profitability of the Company by (i) providing key people and consultants with incentives to improve stockholder value and to contribute to the growth and financial success of the Company and (ii) enabling the Company to attract, retain and reward the best available persons for positions of substantial responsibility. The Plan allows for the grant of: (a) incentive stock options; (b) nonqualified stock options; (c) stock appreciation rights; (d) restricted stock; and (e) other stock-based and cash-based awards to eligible individuals qualifying under Section 422 of the Internal Revenue Code, in any combination (collectively, “Options”). At June 30, 2017, the Company had 2,294,018 shares of Common Stock available for issuance under the Plan. A summary of the Plan Options for the six months ended June 30, 2017 is presented in the following table: Number of Shares Weighted Average Exercise Price Aggregate Intrinsic Value (in thousands) Outstanding December 31, 2016 1,660,964 $ 4.74 $ 1,346 Issued 76,547 2.07 Canceled / expired (54,332 ) 4.28 Exercised (6,321 ) 4.19 - Outstanding June 30, 2017 1,676,858 $ 4.63 $ 3,145 Exercisable June 30, 2017 959,533 $ 4.35 $ 2,079 The weighted-average fair value per share of the granted options for the six months ended June 30, 2017 and 2016 was approximately $3.08 and $2.93, respectively. Stock based compensation expense included in the condensed consolidated statements of operations was $358,000 and $56,000 for the three months ended June 30, 2017 and 2016, respectively, and $485,000 and $126,000 for the six months ended June 30, 2017 and 2016, respectively. As of June 30, 2017, there was approximately $1,828,000 of total unrecognized compensation expense related to unvested share-based compensation arrangements granted under the Plan. The expense is expected to be recognized over a weighted-average period of 3.93 years. The Company uses the Black-Scholes option-pricing model (“Black-Scholes model”) to estimate the fair value of stock option grants. The use of a valuation model requires the Company to make certain assumptions with respect to selected model inputs. Expected volatility is calculated based on the historical volatility of the Company’s stock price over the expected term of the option. The expected life is based on the contractual life of the option and expected employee exercise and post-vesting employment termination behavior. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of the grant. |
Segment and Geographical Inform
Segment and Geographical Information | 6 Months Ended |
Jun. 30, 2017 | |
Notes to Financial Statements | |
Segment and Geographical Information | We are a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers products from top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. We operate in two segments: the direct selling segment where products are offered through a global distribution network of preferred customers and distributors and the commercial coffee segment where roasted and green coffee bean products are sold directly to businesses. The Company’s segments reflect the manner in which the business is managed and how the Company allocates resources and assesses performance. The Company’s chief operating decision maker is the Chief Executive Officer. The Company’s chief operating decision maker evaluates segment performance primarily based on revenue and segment operating income. The principal measures and factors the Company considered in determining the number of reportable segments were revenue, gross margin percentage, sales channel, customer type and competitive risks. In addition, each reporting segment has similar products and customers, similar methods of marketing and distribution and a similar regulatory environment. The accounting policies of the segments are consistent with those described in the summary of significant accounting policies. Segment revenue excludes intercompany revenue eliminated in the consolidation. The following tables present certain financial information for each segment (in thousands): Three months ended Six months ended June 30, June 30, 2017 2016 2017 2016 Revenues Direct selling $ 35,538 $ 37,019 $ 68,780 $ 71,817 Commercial coffee 5,989 5,481 11,480 8,885 Total revenues $ 41,527 $ 42,500 $ 80,260 $ 80,702 Gross profit Direct selling $ 24,195 $ 24,967 $ 46,050 $ 48,457 Commercial coffee (93 ) 464 (82 ) 337 Total gross profit $ 24,102 $ 25,431 $ 45,968 $ 48,794 Operating income (loss) Direct selling $ 595 $ 1,708 $ (1,159 ) $ 3,732 Commercial coffee (1,271 ) (184 ) (1,917 ) (1,045 ) Total operating income $ (676 ) $ 1,524 $ (3,076 ) $ 2,687 Net (loss) income Direct selling $ (135 ) $ 416 $ (1,647 ) $ 1,090 Commercial coffee (2,595 ) (525 ) (3,142 ) (1,048 ) Total net (loss) income $ (2,730 ) $ (109 ) $ (4,789 ) $ 42 Capital expenditures Direct selling $ 346 $ 398 $ 474 $ 749 Commercial coffee 101 299 281 718 Total capital expenditures $ 447 $ 697 $ 755 $ 1,467 As of June 30, 2017 December 31, 2016 Total assets Direct selling $ 42,821 $ 40,127 Commercial coffee 26,462 25,881 Total assets $ 69,283 $ 66,008 Total tangible assets, net located outside the United States were approximately $5.3 million and $5.4 million as of June 30, 2017 and December 31, 2016, respectively. The Company conducts its operations primarily in the United States. For the three months ended June 30, 2017 and 2016 approximately 10% and 9%, respectively, of the Company’s sales were derived from sales outside the United States. For the six months ended June 30, 2017 and 2016 approximately 10% and 9%, respectively, of the Company’s sales were derived from sales outside the United States. The following table displays revenues attributable to the geographic location of the customer (in thousands): Three months ended Six months ended June 30, June 30, 2017 2016 2017 2016 Revenues United States $ 37,378 $ 38,739 $ 72,212 $ 73,702 International 4,149 3,761 8,048 7,000 Total revenues $ 41,527 $ 42,500 $ 80,260 $ 80,702 |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2017 | |
Subsequent Events [Abstract] | |
Subsequent Events | July 2017 Private Placement On July 28, 2017, the Company, closed the first tranche of its July 2017 Private Placement offering (the “Offering”) pursuant to which the Company offered for sale a minimum of $100,000 of units up to a maximum of $10,000,000 of units, with each unit (a “Unit”) consisting of: (i) a three (3) year convertible note in the principal amount of $25,000 (the “Note or Notes”) initially convertible into shares of the Company’s Common Stock, at $4.60 per share (subject to adjustment); and (ii) Series D Warrant (the “Class D Warrant” or “Warrant(s)”), exercisable to purchase 50% of the number of shares issuable upon conversion of the Note at an exercise price equal to $5.56. On July 28, 2017, the Company entered into a Note Purchase Agreement with eight (8) accredited investors pursuant to which the Company raised gross cash proceeds of $2,100,000 in the Offering and sold Notes in the aggregate principal amount of $2,100,000, convertible into 456,522 shares of the Company’s Common Stock, at a conversion price of $4.60 per share, subject to adjustment as provided therein; and Warrants to purchase 228,261 shares of Common Stock at an exercise price of $5.56. In addition, as part of the Offering, three (3) investors in the Company’s November 2015 Private Placement (the “Prior Investors”), converted their 8% Series C Convertible Notes in the aggregate principal amount of $4,200,349 together with accrued interest thereon into new convertible notes for an equal principal amount, convertible into 913,119 shares of Common Stock and class D warrants to purchase an aggregate of 456,560 shares of Common Stock. The new note will carry the same interest rate as the prior note. The Prior Investors also agreed to exchange their Series A Warrants dated October 26, 2015 to purchase an aggregate of 279,166 shares of Common Stock for a new warrant to purchase an aggregate of 182,065 shares of Common Stock (see Note 6 above “November 2015 Private Placement”). The Offering was extended an additional thirty (30) days from the initial closing date of July 31, 2017. The Company intends to use the proceeds for working capital purposes. For twelve (12) months following the closing, the investors have the right to participate in any future equity financings by the Company up to their pro rata share of the maximum offering amount in the aggregate. The Notes bear interest at a rate of eight percent (8%) per annum. The Company has the right to prepay the Notes at any time after the one year anniversary date of the issuance of the Notes at a rate equal to 110% of the then outstanding principal balance and accrued interest. The Notes automatically convert to Common Stock if prior to the maturity date the Company sells Common Stock, preferred stock or other equity-linked securities with aggregate gross proceeds of no less than $3,000,000 for the purpose of raising capital. The Notes provide for full ratchet price protection for a period of nine months after their issuance and thereafter weighted average price adjustment. In connection with the Offering, the Company also entered into a registration rights agreement with the investors in the Offering (the “ Registration Rights Agreement Initial Registration Statement Filing Date Registrable Securities Effectiveness Date Event The Company paid a placement fee of $262,008, excluding legal expenses, and has agreed to issue to the Placement Agent three-year warrants to purchase 159,817 shares of Common Stock at an exercise price of $5.56 per share and the Company has agreed to issue the Placement Agent 22,680 shares of the Company’s Common Stock. Acquisition Sorvana International, LLC Effective July 1, 2017, the Company acquired certain assets and assumed certain liabilities of Sorvana International “Sorvana”. Sorvana was the result of the unification of the two companies FreeLife International, Inc. “FreeLife”, and L’dara. Sorvana offers a variety of products with the addition of the FreeLife and L’dara product lines. Sorvana offers an extensive line of health and wellness product solutions including healthy weight loss supplements, energy and performance products and skin care product lines as well as organic product options. As a result of this business combination, the Company’s distributors and customers will have access to Sorvana’s unique line of products and Sorvana’s distributors and clients will gain access to products offered by the Company. The maximum consideration payable by the Company shall be $14,000,000, subject to adjustments. The Company will make monthly payments based on a percentage of Sorvana’s distributor revenue and royalty revenue until the earlier of the date that is twelve (12) years from the closing date or such time as the Company has paid Sorvana’s aggregate cash payments of Sorvana’s distributor revenue and royalty revenue equal to the maximum aggregate purchase price. The final purchase price allocation has not been determined as of the filing of this report. Grant of Restricted Stock Units and Stock Options On August 9, 2017, the Company granted an aggregate of 500,000 restricted stock units, each unit representing a contingent right to receive one share of Common Stock vesting as follows: (i) Year 3 - 50,000 shares; (ii) Year 4 – 75,000 shares; (iii) Year 5 - 250,000 shares; and (iv) Year 6 – 125,000 shares; provided that the grantee continues to serve as an executive officer, employee or consultant, as applicable or otherwise is not terminated for cause prior to such dates. Included in the grants was a grant to Mr. Briskie of 250,000 restricted stock units. The Company also granted ten year options to purchase an aggregate of 20,000 shares of Common Stock to Messrs. Renton, Sallwasser, Allodi and Thompson (a grant of an option to purchase 5,000 shares of Common Stock to each), having an exercise price of $4.53 vesting immediately. |
Basis of Presentation and Des18
Basis of Presentation and Description of Business (Policies) | 6 Months Ended |
Jun. 30, 2017 | |
Basis Of Presentation And Description Of Business Policies | |
Basis of Presentation | The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted pursuant to such rules and regulations. The statements presented as of June 30, 2017 and for the three and six months ended June 30, 2017 and 2016 are unaudited. In the opinion of management, these financial statements reflect all normal recurring and other adjustments necessary for a fair presentation, and to make the financial statements not misleading. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Form 10-K for the year ended December 31, 2016. The results for interim periods are not necessarily indicative of the results for the entire year. Youngevity International, Inc. (the “Company”) consolidates all wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications have been made to conform to the current year presentations including the Company’s adoption of Accounting Standards Update (“ASU”) 2015-17 pertaining to the presentation of deferred tax assets and liabilities as noncurrent with retrospective application effective January 1, 2017. This resulted in a reclassification from deferred tax assets, net current to deferred tax assets, net long-term deferred tax assets, net long-term As previously reported on the Annual Report on Form 10-K/A for the year ended December 31, 2016 filed with the Securities and Exchange Commission on August 14, 2017, the Company restated the interim Consolidated Statement of Cash Flows for the quarter ended June 30, 2016 previously filed by the Company in its quarterly report on Form 10-Q for the same period. This was due to an error in the presentation of cash flow activity under the Company’s factoring facility. The current report for the quarter ended June 30, 2017 reflects the restated numbers for the six months ended June 30, 2016. |
Nature of Business | The Company, founded in 1996, develops and distributes health and nutrition related products through its global independent direct selling network, also known as multi-level marketing, and sells coffee products to commercial customers. The Company operates in two business segments, its direct selling segment where products are offered through a global distribution network of preferred customers and distributors and its commercial coffee segment where products are sold directly to businesses. In the following text, the terms “we,” “our,” and “us” may refer, as the context requires, to the Company or collectively to the Company and its subsidiaries. The Company operates through the following domestic wholly-owned subsidiaries: AL Global Corporation, which operates our direct selling networks, CLR Roasters, LLC (“CLR”), our commercial coffee business, 2400 Boswell LLC, MK Collaborative LLC, Youngevity Global LLC and the wholly-owned foreign subsidiaries Youngevity Australia Pty. Ltd., Youngevity NZ, Ltd., Siles Plantation Family Group S.A. (“Siles”), located in Nicaragua, Youngevity Mexico S.A. de CV, Youngevity Israel, Ltd., Youngevity Russia, LLC, Youngevity Colombia S.A.S, Youngevity International Singapore Pte. Ltd., Mialisia Canada, Inc., Legacy for Life Limited (Hong Kong), BellaVita Group LLC; Taiwan, Hong Kong, Singapore, Indonesia, Malaysia and Japan. The Company also operates subsidiary branches of Youngevity Global LLC in the Philippines and Taiwan. |
Reverse Stock Split | On June 5, 2017, the Company filed a certificate to amend its Articles of Incorporation to effect a reverse split on a one-for-twenty basis (the “Reverse Split”), whereby, every twenty shares of the Company’s common stock, par value $0.001 per share (the “Common Stock or “common stock”), were exchanged for one share of its common stock. The Reverse Split became effective on June 7, 2017. All common stock share and per share amounts have been adjusted to reflect retrospective application of the Reverse Split, unless otherwise indicated. The Common Stock began trading on a reverse split basis at the market opening on June 8, 2017. |
NASDAQ Listing | Effective June 21, 2017, the Common Stock began trading on the NASDAQ Stock Market LLC’s NASDAQ Capital Market, under the symbol “YGYI”. Prior to the Company’s uplisting to NASDAQ the Company’s common stock had been traded on the OTCQX market. |
Use of Estimates | The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense for each reporting period. Estimates are used in accounting for, among other things, allowances for doubtful accounts, deferred taxes, and related valuation allowances, fair value of derivative liabilities, uncertain tax positions, loss contingencies, fair value of options granted under our stock based compensation plan, fair value of assets and liabilities acquired in business combinations, capital leases, asset impairments, estimates of future cash flows used to evaluate impairments, useful lives of property, equipment and intangible assets, value of contingent acquisition debt, inventory obsolescence, and sales returns. Actual results may differ from previously estimated amounts and such differences may be material to the condensed consolidated financial statements. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected prospectively in the period they occur. |
Liquidity | We believe that current cash balances, future cash provided by operations, and available amounts under our accounts receivable factoring agreement will be sufficient to cover our operating and capital needs in the ordinary course of business for at least the next twelve months as of August 14, 2017. Though our operations are currently meeting our working capital requirements, if we experience an adverse operating environment or unusual capital expenditure requirements, or if we continue our expansion internationally or through acquisitions, additional financing may be required. No assurance can be given, however, that additional financing, if required, would be available on favorable terms. We might also require or seek additional financing for the purpose of expanding into new markets, growing our existing markets, or for other reasons. Such financing may include the use of additional debt or the sale of additional equity securities. Any financing which involves the sale of equity securities or instruments that are convertible into equity securities could result in immediate and possibly significant dilution to our existing shareholders. |
Cash and Cash Equivalents | The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents. |
Earnings Per Share | Basic earnings (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income attributable to common stockholders by the sum of the weighted-average number of common shares outstanding during the period and the weighted-average number of dilutive common share equivalents outstanding during the period, using the treasury stock method. Dilutive common share equivalents are comprised of in-the-money stock options, warrants and convertible preferred stock and Common Stock associated with the Company's convertible notes based on the average stock price for each period using the treasury stock method. Since the Company incurred a loss for the three and six months ended June 30, 2017, 5,282,208 common share equivalents were not included in the weighted-average calculations since their effect would have been anti-dilutive. The Company incurred a loss for the three months ended June 30, 2016, and therefore, 4,866,703 common share equivalents including potential convertible shares of Common Stock associated with the Company's convertible notes were not included in the weighted-average calculation since their effect would have been anti-dilutive. The incremental dilutive common share equivalents were 1,380,915 for the six months ended June 30, 2016. Income and loss per share amounts and weighted average shares outstanding for all periods have been retroactively adjusted to reflect the Company’s 1-for-20 Reverse Split, which was effective June 7, 2017. |
Stock Based Compensation | The Company accounts for stock based compensation in accordance with ASC Topic 718, “ Compensation – Stock Compensation,” The Company accounts for equity instruments issued to non-employees in accordance with authoritative guidance for equity based payments to non-employees. Stock options issued to non-employees are accounted for at their estimated fair value, determined using the Black-Scholes option-pricing model. The fair value of options granted to non-employees is re-measured as they vest, and the resulting increase in value, if any, is recognized as expense during the period the related services are rendered. |
Factoring Agreement | The Company has a factoring agreement (“Factoring Agreement”) with Crestmark Bank (“Crestmark”) related to the Company’s accounts receivable resulting from sales of certain products within its commercial coffee segment. Effective May 1, 2016, the Company entered into a third amendment to the factoring agreement (“Agreement”). Under the terms of the Agreement, all new receivables assigned to Crestmark shall be “Client Risk Receivables” and no further credit approvals will be provided by Crestmark. Additionally, the Agreement expands the factoring facility to include advanced borrowings against eligible inventory up to 50% of landed cost of finished goods inventory that meet certain criteria, not to exceed the lesser of $1,000,000 or 85% of the value of the accounts receivables already advanced with a maximum overall borrowing of $3,000,000. Interest accrues on the outstanding balance and a factoring commission is charged for each invoice factored which is calculated as the greater of $5.00 or 0.75% to 0.875% of the gross invoice amount and is recorded as interest expense. In addition, the Company and the Company’s CEO, Mr. Wallach have entered into a Guaranty and Security Agreement with Crestmark Bank guaranteeing payments in the event that CLR were to default. This Agreement is effective until February 1, 2019. The Company accounts for the sale of receivables under the Factoring Agreement as secured borrowings with a pledge of the subject inventories and receivables as well as all bank deposits as collateral, in accordance with the authoritative guidance for accounting for transfers and servicing of financial assets and extinguishments of liabilities. The caption “Accounts receivable, due from factoring company” on the accompanying condensed consolidated balance sheets in the amount of approximately $2,743,000 and $1,078,000 as of June 30, 2017 and December 31, 2016, respectively, reflects the related collateralized accounts. The Company's outstanding liability related to the Factoring Agreement was approximately $2,942,000 and $1,290,000 as of June 30, 2017 and December 31, 2016, respectively, and is included in other current liabilities on the condensed consolidated balance sheets. |
Plantation Costs | The Company’s commercial coffee segment CLR includes the results of the Siles Plantation Family Group (“Siles”), which is a 500 acre coffee plantation and a dry-processing facility located on 26 acres both located in Matagalpa, Nicaragua. Siles is a wholly-owned subsidiary of CLR, and the results of CLR include the depreciation and amortization of capitalized costs, development and maintenance and harvesting costs of Siles. In accordance with US generally accepted accounting principles (“GAAP”), plantation maintenance and harvesting costs for commercially producing coffee farms are charged against earnings when sold. Deferred harvest costs accumulate throughout the year, and are expensed over the remainder of the year as the coffee is sold. The difference between actual harvest costs incurred and the amount of harvest costs recognized as expense is recorded as either an increase or decrease in deferred harvest costs, which is reported as an asset and included with prepaid expenses and other current assets in the condensed consolidated balance sheets. Once the harvest is complete, the harvest cost is then recognized as the inventory value. As of December 31, 2016, the inventory related to the 2016 harvest was $112,000. As of June 30, 2017, all previously harvested coffee from the 2016 harvest had been sold. In April 2017, the Company completed the 2017 harvest in Nicaragua and approximately $552,000 of deferred harvest costs were reclassified as inventory during the quarter ended June 30, 2017. The remaining inventory as of June 30, 2017 is $391,000. Costs associated with the 2018 harvest as of June 30, 2017 total approximately $100,000 and are included in prepaid expenses and other current assets as deferred harvest costs on the Company’s condensed consolidated balance sheets. |
Related Party Transactions | Richard Renton Richard Renton is a member of the Board of Directors and owns and operates with his wife Roxanna Renton, Northwest Nutraceuticals, Inc., a supplier of certain inventory items sold by the Company. The Company made purchases of approximately $59,000 and $16,000 from Northwest Nutraceuticals Inc., for the three months ended June 30, 2017 and 2016, respectively, and $81,000 and $50,000 for the six months ended June 30, 2017 and 2016, respectively. In addition, Mr. Renton and his wife are distributors of the Company and can earn commissions on product sales. Other Relationships Hernandez, Hernandez, Export Y Company The Company’s coffee segment, CLR, is associated with Hernandez, Hernandez, Export Y Company (“H&H”), a Nicaragua company, through sourcing arrangements to procure Nicaraguan green coffee beans and in March 2014 as part of the Siles acquisition, CLR engaged the owners of H&H as employees to manage Siles. The Company made purchases of approximately $912,000 and $2,900,000 from this supplier for the three months ended June 30, 2017 and 2016, respectively and $1,327,000 and $4,700,000 for the six months ended June 30, 2017 and 2016, respectively. In addition, CLR sold approximately $1,056,000 and $1,500,000 for the three months ended June 30, 2017 and 2016, respectively and $1,547,000 and $2,200,000 for the six months ended June 30, 2017 and 2016, respectively, of green coffee beans to H&H Coffee Group Export, a Florida based company which is affiliated with H&H. In March 2017, the Company entered a settlement agreement and release with H&H Coffee Group Export pursuant to which it was agreed that $150,000 owed to H&H Coffee Group Export for services that had been rendered would be settled by the issuance of Common Stock. During the three months ended June 30, 2017, the Company issued to H&H Coffee Group Export 27,500 shares of Common Stock in accordance with this agreement. In May 2017, the Company entered a settlement agreement with Alain Piedra Hernandez, one of the owners of H&H and the operating manager of Siles, who was issued a non-qualified stock option for the purchase of 75,000 shares of the Company’s Common Stock at a price of $2.00 with an expiration date of three years, in lieu of an obligation due from the Company to H&H as relates to a Sourcing and Supply Agreement with H&H. |
Revenue Recognition | The Company recognizes revenue from product sales when the following four criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. The Company ships the majority of its direct selling segment products directly to the distributors primarily via UPS, USPS or FedEx and receives substantially all payments for these sales in the form of credit card transactions. The Company regularly monitors its use of credit card or merchant services to ensure that its financial risk related to credit quality and credit concentrations is actively managed. Revenue is recognized upon passage of title and risk of loss to customers when product is shipped from the fulfillment facility. The Company ships the majority of its coffee segment products via common carrier and invoices its customer for the products. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. Sales revenue and a reserve for estimated returns are recorded net of sales tax when product is shipped. |
Deferred Revenues and Costs | Deferred revenues relate primarily to the Heritage Makers product line and represent the Company’s obligation for points purchased by customers that have not yet been redeemed for product. Cash received for points sold is recorded as deferred revenue. Revenue is recognized when customers redeem the points and the product is shipped. As of June 30, 2017 and December 31, 2016, the balance in deferred revenues was approximately $1,848,000 and $1,870,000 respectively, of which the portion attributable to Heritage Makers was approximately $1,623,000 and $1,662,000, respectively. The remaining balance of approximately $225,000 and $208,000 as of June 30, 2017 and December 31, 2016, related primarily to the Company’s 2017 conventions, respectively, whereby attendees pre-enroll in the events and the Company does not recognize this revenue until the conventions occur. Deferred costs relate to Heritage Makers prepaid commissions that are recognized in expense at the time the related revenue is recognized. As of June 30, 2017 and December 31, 2016, the balance in deferred costs was approximately $377,000 and $415,000 respectively, and was included in prepaid expenses and current assets. |
Commitments and Contingencies | We are, from time to time, the subject of claims and suits arising out of matters occurring during the operation of our business. We are not presently party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, current legal proceedings are having an adverse impact on us because of litigation costs, diversion of management resources and other factors. |
Recently Issued Accounting Pronouncements | In October 2016, the FASB issued Accounting Standard Update ("ASU") 2016-17, Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control. This standard amends the guidance issued with ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis in order to make it less likely that a single decision maker would individually meet the characteristics to be the primary beneficiary of a Variable Interest Entity ("VIE"). When a decision maker or service provider considers indirect interests held through related parties under common control, they perform two steps. The second step was amended with this ASU to say that the decision maker should consider interests held by these related parties on a proportionate basis when determining the primary beneficiary of the VIE rather than in their entirety as was called for in the previous guidance. This ASU was effective for fiscal years beginning after December 15, 2016, and early adoption was not permitted. The Company adopted ASU 2016-17 effective the quarter ended March 31, 2017. The adoption of ASU 2016-17 did not have a significant impact on its consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. The Company expects to adopt the standard no later than January 1, 2019. The Company is currently assessing the impact that the new standard will have on the Company’s consolidated financial statements, which will consist primarily of a balance sheet gross up of our operating leases. The Company has not evaluated the impact this new standard will have on its consolidated financial statements; however it is expected to gross-up the consolidated balance sheet as a result of recognizing a lease asset along with a similar lease liability. In November 2015, the FASB issued ASU 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. This guidance requires that entities with a classified statement of financial position present all deferred tax assets and liabilities as noncurrent. This update is effective for annual and interim periods for fiscal years beginning after December 15, 2016, which required the Company to adopt the new guidance in the first quarter of fiscal 2017. Early adoption was permitted for financial statements that have not been previously issued and may be applied on either a prospective or retrospective basis. The Company adopted ASU 2015-17 effective the quarter ended March 31, 2017. The adoption of ASU 2015-17 did not have a significant impact on its consolidated financial statements other than the netting of current and long-term deferred tax assets and liabilities in the non-current section of the balance sheet and footnote disclosures. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, requiring an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The updated standard will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either the retrospective or cumulative effect transition method. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. Accordingly, the updated standard is effective for the Company in the first quarter of fiscal 2018 and we do not plan to early adopt. The Company has not yet selected a transition method and the Company is currently evaluating the effect that the updated standard will have on its consolidated financial statements and related disclosures. |
Inventory and Costs of Revenu19
Inventory and Costs of Revenues (Tables) | 6 Months Ended |
Jun. 30, 2017 | |
Inventory And Cost Of Sales Tables | |
Inventories | As of June 30, 2017 December 31, 2016 Finished goods $ 10,962 $ 11,550 Raw materials 10,776 11,006 21,738 22,556 Reserve for excess and obsolete (1,064 ) (1,064 ) Inventory, net $ 20,674 $ 21,492 |
Acquisitions and Business Com20
Acquisitions and Business Combinations (Tables) | 6 Months Ended |
Jun. 30, 2017 | |
Ricolife, LLC [Member] | |
Assets acquired and liabilities assumed | Distributor organization $ 440 Customer-related intangible 280 Trademarks and trade name 200 Total purchase price $ 920 |
Bellavita Group, LLC [Member] | |
Assets acquired and liabilities assumed | Distributor organization $ 825 Customer-related intangible 525 Trademarks and trade name 400 Total purchase price $ 1,750 |
Intangible Assets and Goodwill
Intangible Assets and Goodwill (Tables) | 6 Months Ended |
Jun. 30, 2017 | |
Intangible Assets And Goodwill Tables | |
Intangible Assets and Goodwill | June 30, 2017 December 31, 2016 Cost Accumulated Amortization Net Cost Accumulated Amortization Net Distributor organizations $ 14,195 $ 7,779 $ 6,416 $ 12,930 $ 7,162 $ 5,768 Trademarks and trade names 5,994 988 5,006 5,394 815 4,579 Customer relationships 8,651 4,136 4,515 7,846 3,642 4,204 Internally developed software 720 408 312 720 357 363 Intangible assets $ 29,560 $ 13,311 $ 16,249 $ 26,890 $ 11,976 $ 14,914 |
Goodwill | June 30, 2017 December 31, 2016 Goodwill, commercial coffee $ 3,314 $ 3,314 Goodwill, direct selling 3,009 3,009 Total goodwill $ 6,323 $ 6,323 |
Debt (Tables)
Debt (Tables) | 6 Months Ended |
Jun. 30, 2017 | |
Debt Tables | |
Convertible note oustanding | June 30, 2017 December 31, 2016 8% Convertible Notes due July and August 2019 (July 2014 Private Placement) (1) $ 2,771 $ 2,296 8% Convertible Notes due October and November 2018 (November 2015 Private Placement) (2) 7,051 6,999 Net debt issuance costs (724 ) (968 ) Total convertible notes payable, net of debt discount (3) $ 9,098 $ 8,327 |
Derivative Liability (Tables)
Derivative Liability (Tables) | 6 Months Ended |
Jun. 30, 2017 | |
Derivative Liability Tables | |
Monte Carlo fair value of warrants | June 30, 2017 December 31, 2016 Stock price volatility 60% - 65 % 60% - 65 % Risk-free interest rates 1.38%-1.55 % 1.34%-1.70 % Annual dividend yield 0 0 Expected life 2.0-3.3 years 2.6-3.9 years |
Fair Value of Financial Instr24
Fair Value of Financial Instruments (Tables) | 6 Months Ended |
Jun. 30, 2017 | |
Fair Value Of Financial Instruments Tables | |
Fair value measurement within the three levels of value hierarchy | Fair Value at June 30, 2017 Total Level 1 Level 2 Level 3 Liabilities: Contingent acquisition debt, current portion $ 359 $ - $ - $ 359 Contingent acquisition debt, less current portion 9,058 - - 9,058 Warrant derivative liability 4,076 - - 4,076 Total liabilities $ 13,493 $ - $ - $ 13,493 Fair Value at December 31, 2016 Total Level 1 Level 2 Level 3 Liabilities: Contingent acquisition debt, current portion $ 628 $ - $ - $ 628 Contingent acquisition debt, less current portion 7,373 - - 7,373 Warrant derivative liability 3,345 - - 3,345 Total liabilities $ 11,346 $ - $ - $ 11,346 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 6 Months Ended |
Jun. 30, 2017 | |
Stock Option Plan Tables | |
Warrant Activity | Balance at December 31, 2016 1,899,385 Issued - Expired / cancelled (15,500 ) Exercised - Balance at June 30, 2017 1,883,885 |
Summary of Plan Options | Number of Shares Weighted Average Exercise Price Aggregate Intrinsic Value (in thousands) Outstanding December 31, 2016 1,660,964 $ 4.74 $ 1,346 Issued 76,547 2.07 Canceled / expired (54,332 ) 4.28 Exercised (6,321 ) 4.19 - Outstanding June 30, 2017 1,676,858 $ 4.63 $ 3,145 Exercisable June 30, 2017 959,533 $ 4.35 $ 2,079 |
Segment and Geographical Info26
Segment and Geographical Information (Tables) | 6 Months Ended |
Jun. 30, 2017 | |
Segment And Geographical Information Tables | |
Segment information revenue | Three months ended Six months ended June 30, June 30, 2017 2016 2017 2016 Revenues Direct selling $ 35,538 $ 37,019 $ 68,780 $ 71,817 Commercial coffee 5,989 5,481 11,480 8,885 Total revenues $ 41,527 $ 42,500 $ 80,260 $ 80,702 Gross profit Direct selling $ 24,195 $ 24,967 $ 46,050 $ 48,457 Commercial coffee (93 ) 464 (82 ) 337 Total gross profit $ 24,102 $ 25,431 $ 45,968 $ 48,794 Operating income (loss) Direct selling $ 595 $ 1,708 $ (1,159 ) $ 3,732 Commercial coffee (1,271 ) (184 ) (1,917 ) (1,045 ) Total operating income $ (676 ) $ 1,524 $ (3,076 ) $ 2,687 Net (loss) income Direct selling $ (135 ) $ 416 $ (1,647 ) $ 1,090 Commercial coffee (2,595 ) (525 ) (3,142 ) (1,048 ) Total net (loss) income $ (2,730 ) $ (109 ) $ (4,789 ) $ 42 Capital expenditures Direct selling $ 346 $ 398 $ 474 $ 749 Commercial coffee 101 299 281 718 Total capital expenditures $ 447 $ 697 $ 755 $ 1,467 |
Segment information assets | As of June 30, 2017 December 31, 2016 Total assets Direct selling $ 42,821 $ 40,127 Commercial coffee 26,462 25,881 Total assets $ 69,283 $ 66,008 |
Segment information geographical | Three months ended Six months ended June 30, June 30, 2017 2016 2017 2016 Revenues United States $ 37,378 $ 38,739 $ 72,212 $ 73,702 International 4,149 3,761 8,048 7,000 Total revenues $ 41,527 $ 42,500 $ 80,260 $ 80,702 |
Basis of Presentation and Des27
Basis of Presentation and Description of Business (Details Narrative) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 |
Accounts receivable, due from factoring company | $ 2,743 | $ 1,078 |
Inventory | 391 | |
Deferred revenues | 1,848 | 1,870 |
Deferred costs | $ 377 | 415 |
2017 Harvest [Member] | ||
Prepaid costs | $ 452 |
Inventory and Costs of Revenu28
Inventory and Costs of Revenues (Details) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 |
Inventory And Cost Of Sales Details | ||
Finished goods | $ 10,962 | $ 11,550 |
Raw materials | 10,776 | 11,006 |
Total inventory | 21,738 | 22,556 |
Reserve for excess and obsolete inventory | (1,064) | (1,064) |
Total inventory, net | $ 20,674 | $ 21,492 |
Acquisitions and Business Com29
Acquisitions and Business Combinations (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2017USD ($) | |
Bellavita Group, LLC [Member] | |
Total purchase price | $ 1,750 |
Bellavita Group, LLC [Member] | Distributor organizations [Member] | |
Total purchase price | 825 |
Bellavita Group, LLC [Member] | Customer-related intangible [Member] | |
Total purchase price | 525 |
Bellavita Group, LLC [Member] | Trademarks and trade name [Member] | |
Total purchase price | 400 |
Ricolife, LLC [Member] | |
Total purchase price | 920 |
Ricolife, LLC [Member] | Distributor organizations [Member] | |
Total purchase price | 440 |
Ricolife, LLC [Member] | Customer-related intangible [Member] | |
Total purchase price | 280 |
Ricolife, LLC [Member] | Trademarks and trade name [Member] | |
Total purchase price | $ 200 |
Acquisitions and Business Com30
Acquisitions and Business Combinations (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2017 | Jun. 30, 2016 | |
Revenue | $ 41,527 | $ 42,500 | $ 80,260 | $ 80,702 |
Ricolife, LLC [Member] | ||||
Fair value at date of acquisition | 920 | |||
Revenue | 351 | 415 | ||
Bellavita Group, LLC [Member] | ||||
Fair value at date of acquisition | 1,750 | |||
Revenue | $ 620 | $ 872 |
Intangible Assets and Goodwil31
Intangible Assets and Goodwill (Details) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 |
Distributor organizations [Member] | ||
Cost | $ 14,195 | $ 12,930 |
Accumulated Amortization | 7,779 | 7,162 |
Net | 6,416 | 5,768 |
Trademarks and trade names [Member] | ||
Cost | 5,994 | 5,394 |
Accumulated Amortization | 988 | 815 |
Net | 5,006 | 4,579 |
Customer relationships [Member] | ||
Cost | 8,651 | 7,846 |
Accumulated Amortization | 4,136 | 3,642 |
Net | 4,515 | 4,204 |
Internally developed software [Member] | ||
Cost | 720 | 720 |
Accumulated Amortization | 408 | 357 |
Net | 312 | 363 |
Intangible assets [Member] | ||
Cost | 29,560 | 26,890 |
Accumulated Amortization | 13,311 | 11,976 |
Net | $ 16,249 | $ 14,914 |
Intangible Assets and Goodwil32
Intangible Assets and Goodwill (Details 1) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 |
Goodwill | $ 6,323 | $ 6,323 |
Commercial Coffee [Member] | ||
Goodwill | 3,314 | 3,314 |
Direct Selling [Member] | ||
Goodwill | $ 3,009 | $ 3,009 |
Intangible Assets and Goodwil33
Intangible Assets and Goodwill (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2017 | Jun. 30, 2016 | Dec. 31, 2016 | |
Intangible Assets And Goodwill Details Narrative | |||||
Amortization expense | $ 690 | $ 605 | $ 1,335 | $ 1,209 | |
Trademarks | 2,267 | 2,267 | |||
Goodwill balance | $ 6,323 | $ 6,323 | $ 6,323 |
Debt (Details)
Debt (Details) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 | |
Net debt issuance costs | $ (724) | $ (968) | |
Total convertible notes payable, net of debt discount | [1] | 9,098 | 8,327 |
Convertible Notes Payable 1 [Member] | |||
Convertible notes issued | [2] | 2,771 | 2,296 |
Convertible Notes Payable 2 [Member] | |||
Convertible notes issued | [3] | $ 7,051 | $ 6,999 |
[1] | Principal amounts are net of unamortized debt discounts and issuance costs of $3,226,000 as of March 31, 2017 and $3,611,000 as of December 31, 2016. | ||
[2] | Principal amount of $4,750,000 is net of unamortized debt discounts of $2,216,000 as of March 31, 2017 and $2,454,000 as of December 31, 2016. | ||
[3] | Principal amount of approximately $7,188,000 is net of unamortized debt discounts of $163,000 as of March 31, 2017 and $189,000 as of December 31, 2016. |
Debt (Details Narrative)
Debt (Details Narrative) | Jun. 30, 2017USD ($) |
November 2015 Private Placement [Member] | |
Principal outstanding amount remains | $ 7,187,500 |
July 2014 Private Placement [Member] | |
Principal outstanding amount remains | $ 4,750,000 |
Derivative Liability (Details)
Derivative Liability (Details) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2017 | Dec. 31, 2016 | |
Annual dividend yield | 0.00% | 0.00% |
Minimum [Member] | ||
Stock price volatility | 60.00% | 60.00% |
Risk-free interest rate | 1.38% | 1.34% |
Expected life | 2 years | 2 years 7 months 6 days |
Maximum [Member] | ||
Stock price volatility | 65.00% | 65.00% |
Risk-free interest rate | 1.55% | 1.70% |
Expected life | 3 years 3 months 18 days | 3 years 10 months 24 days |
Derivative Liability (Details N
Derivative Liability (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2017 | Jun. 30, 2016 | Dec. 31, 2016 | |
Derivative Liability Details Narrative | |||||
Warrant derivative liability | $ 4,076 | $ 4,076 | $ 3,345 | ||
Increase/decrease to derivative liability | $ 1,341 | $ 484 | $ 731 | $ 166 |
Fair Value of Financial Instr38
Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 |
Liabilities: | ||
Contingent acquisition debt, current portion | $ 359 | $ 628 |
Contingent acquisition debt, less current portion | 9,058 | 7,373 |
Warrant derivative liability | 4,076 | 3,345 |
Total liabilities | 13,493 | 11,346 |
Level 1 [Member] | ||
Liabilities: | ||
Contingent acquisition debt, current portion | 0 | 0 |
Contingent acquisition debt, less current portion | 0 | 0 |
Warrant derivative liability | 0 | 0 |
Total liabilities | 0 | 0 |
Level 2 [Member] | ||
Liabilities: | ||
Contingent acquisition debt, current portion | 0 | 0 |
Contingent acquisition debt, less current portion | 0 | 0 |
Warrant derivative liability | 0 | 0 |
Total liabilities | 0 | 0 |
Level 3 [Member] | ||
Liabilities: | ||
Contingent acquisition debt, current portion | 359 | 628 |
Contingent acquisition debt, less current portion | 9,058 | 7,373 |
Warrant derivative liability | 4,076 | 3,345 |
Total liabilities | $ 13,493 | $ 11,346 |
Fair Value of Financial Instr39
Fair Value of Financial Instruments (Details Narratives) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2017 | Jun. 30, 2016 | |
Notes to Financial Statements | ||
Change in fair value of contingent acquisition debt | $ (680) | $ (871) |
Stockholders' Equity (Details)
Stockholders' Equity (Details) | 6 Months Ended |
Jun. 30, 2017shares | |
Stock Option [Member] | |
Number of Shares | |
Outstanding, beginning of period | 1,660,964 |
Issued | 76,547 |
Expired / cancelled | (54,332) |
Exercised | (6,321) |
Outstanding, end of period | 1,676,858 |
Warrant [Member] | |
Number of Shares | |
Outstanding, beginning of period | 1,899,385 |
Issued | 0 |
Expired / cancelled | (15,500) |
Exercised | 0 |
Outstanding, end of period | 1,883,885 |
Stockholders' Equity (Details 1
Stockholders' Equity (Details 1) $ / shares in Units, $ in Thousands | 6 Months Ended |
Jun. 30, 2017USD ($)$ / sharesshares | |
Stock Option [Member] | |
Number of Shares | |
Outstanding, beginning of period | 1,660,964 |
Granted | 76,547 |
Canceled / expired | (54,332) |
Exercised | (6,321) |
Outstanding, end of period | 1,676,858 |
Exercisable, end of period | 959,533 |
Outstanding, beginning of period | $ / shares | $ 4.74 |
Granted | $ / shares | 2.07 |
Canceled / expired | $ / shares | 4.28 |
Exercised | $ / shares | 4.19 |
Outstanding, end of period | $ / shares | 4.63 |
Exercisable, end of period | $ / shares | $ 4.35 |
Aggregate Intrinsic Value | |
Outstanding, beginning of period | $ | $ 1,346 |
Exercised | $ | 0 |
Outstanding, end of period | $ | 3,145 |
Exercisable, end of period | $ | $ 2,079 |
Warrant [Member] | |
Number of Shares | |
Outstanding, beginning of period | 1,899,385 |
Granted | 0 |
Canceled / expired | (15,500) |
Exercised | 0 |
Outstanding, end of period | 1,883,885 |
Stockholders' Equity (Details N
Stockholders' Equity (Details Narrative) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 |
Convertible Preferred Stock, shares outstanding | 161,135 | 161,135 |
Accrued dividends | $ 112 | |
Common Stock, shares outstanding | 19,668,166 | 19,634,345 |
Series A Preferred Stock [Member] | ||
Convertible Preferred Stock, shares outstanding | 161,135 |
Segment and Geographical Info43
Segment and Geographical Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2017 | Jun. 30, 2016 | |
Revenues | $ 41,527 | $ 42,500 | $ 80,260 | $ 80,702 |
Gross profit | 24,102 | 25,431 | 45,968 | 48,794 |
Operating (loss) income | (676) | 1,524 | (3,076) | 2,687 |
Net income (loss) | (2,730) | (109) | (4,789) | 42 |
Capital expenditures | 447 | 697 | 755 | 1,467 |
Direct Selling [Member] | ||||
Revenues | 35,538 | 37,019 | 68,780 | 71,817 |
Gross profit | 24,195 | 24,967 | 46,050 | 48,457 |
Operating (loss) income | 595 | 1,708 | (1,159) | 3,732 |
Net income (loss) | (135) | 416 | (1,647) | 1,090 |
Capital expenditures | 346 | 398 | 474 | 749 |
Commercial Coffee [Member] | ||||
Revenues | 5,989 | 5,481 | 11,480 | 8,885 |
Gross profit | (93) | 464 | (82) | 337 |
Operating (loss) income | (1,271) | (184) | (1,917) | (1,045) |
Net income (loss) | (2,595) | (525) | (3,142) | (1,048) |
Capital expenditures | $ 101 | $ 299 | $ 281 | $ 718 |
Segment and Geographical Info44
Segment and Geographical Information (Details 1) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 |
Total assets | $ 69,283 | $ 66,008 |
Direct Selling [Member] | ||
Total assets | 42,821 | 40,127 |
Commercial Coffee [Member] | ||
Total assets | $ 26,462 | $ 25,881 |
Segment and Geographical Info45
Segment and Geographical Information (Details 2) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2017 | Jun. 30, 2016 | |
Total revenues | $ 41,527 | $ 42,500 | $ 80,260 | $ 80,702 |
United States [Member] | ||||
Total revenues | 37,378 | 38,739 | 72,212 | 73,702 |
International [Member] | ||||
Total revenues | $ 4,149 | $ 3,761 | $ 8,048 | $ 7,000 |
Segment and Geographical Info46
Segment and Geographical Information (Details Narrative) - USD ($) $ in Thousands | Jun. 30, 2017 | Dec. 31, 2016 |
Tangible assets | $ 5,400 | |
International [Member] | ||
Tangible assets | $ 5,300 |